Browsing: Pulmonary

Endocrine Secondary Art.jpg
Thyroid storm is a potentially fatal manifestation of untreated thyrotoxicosis and may result in cardiopulmonary dysfunction. Cardiopulmonary failure is potentially reversible with prompt antithyroid
CCA - ECLS SHOCK.jpg
The ECLS-SHOCK Trial investigated whether extracorporeal life support would benefit patients suffering acute myocardial infarction complicated by cardiogenic shock. Is VA-ECMO always the answer?
Pneumothorax Anchor Art.jpg
The leading cause of iatrogenic pneumothorax is transthoracic needle aspiration. In our case, however, pneumothorax was most likely due to transbronchial lung biopsy two days prior to presentation. Al
CCA - TAME.jpg
This Critical Care Alert examines a study of targeted mild hypercapnia versus normocapnia for patients who achieved ROSC after out-of-hospital cardiac arrest.
Stroke Anchor Art.jpg
Concurrent acute ischemic stroke and submassive pulmonary embolism is a rare occurrence, and there is no sufficient evidence to support a particular method of management. It is important to weigh the
CCD - HFNC Woman Reading on High Velocity Therapy.png
Heated high-flow nasal cannula (HFNC) is capable of delivering 100% humidified and heated oxygen at higher flow rates, providing important support for patients with respiratory distress. Learn more ab
CCA - CapeCod.jpg
The CAPE-COD Trial indicates it might be worth your time to consider hydrocortisone in managing community-acquired pneumonia in admitted patients boarding in the emergency department.
Ultrasound Anchor Art.jpg
In the setting of a malignant pericardial effusion with tamponade and pulmonary embolism, medical management can be difficult due the need for heparinization as well as pericardiocentesis. In a peri-s
48-6 COVID Pericardial Effusion.png
Recently, a series of case reports have described the effect of COVID-19 on myocardial and pericardial tissue. It appears the majority of cases of myocarditis, pericarditis, and pericardial effusions
48-3 Excipient Lung Disease.png
Include excipient lung disease (ELD) in the differential diagnosis when evaluating and treating a patient with a history of intravenous drug use presenting with respiratory failure and typical finding